首页> 美国卫生研究院文献>JCI Insight >Lung vaso-occlusion in sickle cell disease mediated by arteriolar neutrophil-platelet microemboli
【2h】

Lung vaso-occlusion in sickle cell disease mediated by arteriolar neutrophil-platelet microemboli

机译:小动脉中性粒细胞-血小板微栓塞介导的镰状细胞疾病中的肺血管闭塞

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In patients with sickle cell disease (SCD), the polymerization of intraerythrocytic hemoglobin S promotes downstream vaso-occlusive events in the microvasculature. While vaso-occlusion is known to occur in the lung, often in the context of systemic vaso-occlusive crisis and the acute chest syndrome, the pathophysiological mechanisms that incite lung injury are unknown. We used intravital microscopy of the lung in transgenic humanized SCD mice to monitor acute vaso-occlusive events following an acute dose of systemic lipopolysaccharide sufficient to trigger events in SCD but not control mice. We observed cellular microembolism of precapillary pulmonary arteriolar bottlenecks by neutrophil-platelet aggregates. Blood from SCD patients was next studied under flow in an in vitro microfluidic system. Similar to the pulmonary circulation, circulating platelets nucleated around arrested neutrophils, translating to a greater number and duration of neutrophil-platelet interactions compared with normal human blood. Inhibition of platelet P-selectin with function-blocking antibody attenuated the neutrophil-platelet interactions in SCD patient blood in vitro and resolved pulmonary arteriole microembolism in SCD mice in vivo. These results establish the relevance of neutrophil-platelet aggregate formation in lung arterioles in promoting lung vaso-occlusion in SCD and highlight the therapeutic potential of targeting platelet adhesion molecules to prevent acute chest syndrome.
机译:在镰状细胞病(SCD)患者中,红细胞内血红蛋白S的聚合促进了微脉管系统中下游的血管闭塞事件。虽然已知在肺中发生血管闭塞,但通常是在系统性血管闭塞性危机和急性胸腔综合征的背景下,尚不清楚引起肺损伤的病理生理机制。我们在转基因人源化SCD小鼠中使用了肺活体显微镜检查了急性剂量的全身性脂多糖,足以触发SCD而不是对照小鼠的事件后,监测急性血管闭塞事件。我们观察到中性粒细胞血小板聚集的毛细血管前肺小动脉瓶颈的细胞微栓塞。接下来,在体外微流体系统中对SCD患者的血液进行研究。与肺循环相似,循环的血小板在停滞的中性粒细胞周围成核,与正常人血液相比,中性粒细胞-血小板相互作用的数量和持续时间更长。用功能阻断抗体抑制血小板P-选择素在体外减弱了SCD患者血液中的中性粒细胞-血小板相互作用,并在体内解决了SCD小鼠中的肺小动脉微栓塞。这些结果建立了在肺小动脉中嗜中性粒细胞聚集体形成在促进SCD中肺血管闭塞方面的相关性,并突出了靶向血小板粘附分子预防急性胸腔综合征的治疗潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号